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ABSTRACT
The phosphorylation of proteins by proteins kinases plays a central role in the
regulation of cell proliferation, survival, and differentiation. Any alteration in the
phosphorylation state of a cellular protein will induce changes in the activities of the
protein kinases, which can cause many chronic diseases including cancer and diabetes.
Therefore, controlling

kinases activity show the most promise for the development of

anticancer agents. To regulate the activity of the protein kinase, it is important to detect
the phosphorylation event. Using an electrochemical approach to detect the kinase
activity has been achieved by using an electroactive reporter like ferrocene (Fc).
Ferrocene- y labelled ATP serves as a sensing tool for the protein kinase catalyzed
phosphorylation of peptides. The phosphorylation involves the transfer of the Fc-yphosphoryl group from Fc-ATP to the peptide. Here we report the use of this method
with Src kinase. Src kinase (related to Sarcoma virus) is an enzyme which belongs to the
transferase family. Using this method, the kinase activity of Src was motivated by
electrochemical

techniques,

including

cyclic

voltammetiy

(CV),

square

wave

voltammetry (SWV), and differential pulse voltammetry (DPV). The target peptide
EGIYDVP was immobilized on a gold surface and subsequently phosphorylated in the
present of the kinase. In addition, inhibitors were tested to interact with the Src kinase,
which will affect the kinase activity by blocking phosphorylation of substrate peptide.
Here, the following inhibitors were tested 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7tetrahydro-lH-indol-2-yl)methylene]-lH-indole-5-sulfonamide

(SU6656),

(methylphenyl)-7-(t-butyl)pyrazolo-

(PP1),

(3,4d)

pyrimidine

chlorophenyl)-7-(/-butyl)pyrazolo[3,4-d]-pyrimidine

mi

(PP2),

4-amino-5-

4-amino-5-(4jV-benzyl-1-

aminobenzotriazole (TBB), and l-phenyl-Li/-pyrazolo[3,4-£/]pyrimidin-4-amine (PP3).
The kinase kinetics was extracted from the electrochemical measurements to determine
the K„, and the Vmax values.
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CHAPTER 1
1. INTRODUCTION
Enzymes are specialized proteins that catalyze biochemical reactions which could
not otherwise occur under biological condition.1’2 They are highly specific in their action
since they can recognize and act on a specific chemical structure, even in the presence of
similar structures, to produce a specific product.3’4 Consequently, the number of
characterized enzymes are increasing. Enzymes are classified, according to the chemical
reaction they catalyze, into six classes5’6:

•

Oxidoreductases: enzymes are involved in oxidation-reduction reactions.

•

Hydrolases: enzymes are involved in catalyzing hydrolysis o f its substrate.

•

Transferases: enzymes are involved in transferring a chemical group from
one molecule to another.

•

Lyases: enzymes are involved in bond-breaking such as carbon-carbon bonds.

•

Isomerases: enzymes are responsible for moving a chemical group or a
double bond within the same molecule.

•

Ligases: enzymes are involved in joining atoms together.

Research described in this thesis is mainly focused on the transferase family which
consumes energy during the transfer of a functional group from one molecule to another.
Adenosine triphosphate, ATP, represents the main source o f cellular energy required for
the action o f transferases.7 A notable example of transferases is the protein kinase which
catalyzes the phosphorylation o f proteins, where a phosphoryl group from ATP is

1

transferred to the hydroxyl group of serine (Ser), threonine (Thr), or tyrosine (Tyr) in the
protein molecule (Figure 1).1

■

ADP

ATP

w .—

Serine

Threonine

— — i

Tyrosine

Figure 1: Representation the phosphorylation and dephosphorylation reaction of
proteins involving ATP. Hydrolysis of ATP into ADP and inorganic phosphate (Pi),
which will be subsequently attached to the hydroxyl group of amino acids such as
serine (Ser), threonine (Thr), and tyrosine (Tyr). Kinases catalyze the phosphorylation
reaction of the protein, whereas phosphatases catalyze the opposite pathway, namely
de-phosphorylation reaction.
2

In 1980s, knowledge about phosphorylation reactions was expanded with the discovery
that some protein kinases can phosphorylate the tyrosine residues selectively. More than
third of all eukaryotic cellular proteins go through a reversible phosphorylation.2 Studies
also

revealed that some protein kinases themselves require pre-activation by

phosphorylation. The demonstration o f protein kinase cascades was established as a
mechanism for controlling the kinase signalling pathways, which can play a significant
role in controlling the physiology and fonction of cells including cell growth, survival,
metabolism, viability, and enzymatic activity.4’5 Any mutation o f the phosphorylation
state o f a cellular protein might reflect changes in the activities of the corresponding
protein kinases, which can cause many chronic diseases, including cancer and diabetes. ’
Therefore, studying this reaction and monitoring the kinases activity is important for
clinical diagnostics and drug discovery.10

1.1 Mitogen Activated Protein Kinases
Mitogen-activated protein kinase (MAPK) is a family o f protein kinases in
eukaryotes. MAPK was first identified in 1980s, and the name MAPK was used to reflect
its activation by many mitogens and growth factor in different cells.11 The MAPK signal
relay pathway represents one of the best understood mechanisms which are involved in
the transfer o f extracellular signals to their intercellular targets. MAPK catalyzes the
phosphorylation of substrate proteins that can switch the enzyme either ON or OFF.11
Subsequently, phosphorylation o f proteins can control their enzymatic activity, their
interaction with other proteins and molecules, and their relocation within the cell.

3

Therefore, MAPK has a central role in the regulation o f cell proliferation, survival, and
differentiation.12 Generally, kinases control the physiological status of cells by using a
phosphorylation system, where one protein kinase will phosphorylate another protein
(Figure 2).13 During the phosphorylation, kinases transfer a y-phosphate of ATP to the
hydroxyl group o f the Ser, Thr, or Tyr residues in the proteins.10’ 14 The MAPK pathway
is very complex and includes many protein components, which form a complex network
of interacting proteins. In general, MAPKs represent a family o f protein kinases, which
includes the extracellular-signal-regulated kinase (ERKs) function in cell division
regulation. Additionally, inhibitors of these enzymes have been explored as anticancer
agents.10,15

0U

il
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oII

H O -P -O -P -O -P -O *
1
I
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O' O'
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h 2o
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0
0
0
M
M
II
O -P -O -P -O * + H 0 - P - 0 '

i

i

cr o*
ADP

i

O'
P-

Figure 2: The sequence of kinase-catalyzed phosphorylation, starting from
MAPKKK, which activates the phosphorylation of MAPKK, which in turn,
activates the phosphorylation of MAPK in a cascade fashion.

Importantly, the p38 MAPKs are activated by inflammatory cytokines and environmental
stresses.11 ERK plays a central function in MAPK pathway. 15 It serves as a vehicle to
4

transfer the signals from the plasma membrane to the intercellular targets. The discovery
of the link between the ERK pathway and the tumor growth has put the ERK pathway
into the spot light. Based on that, controlling kinases activity and evaluating the
ERK/MAPK pathway show the most promise for the development o f anticancer agents.15

1.2 Tyrosine Kinases
Tyr kinase-catalyzed phosphorylations involve the transfer of a phosphate group
from ATP to a nucleophilic acceptor group on the tyrosine side chain of the substrate
(Figure l ) . '8 Almost 90 of 500 protein kinases phosphorylate Tyr residues.19’ 8 Tyrosine
kinases can be divided into 58 receptor tyrosine kinases and 32 non-receptor tyrosine
kinases. The members of receptor tyrosine kinases are responsible for transducing signals
from extracellular ligands to intracellular signalling pathways.19 Non-receptor tyrosine
kinases are cytoplasmic proteins that do not directly interact with extracellular ligands but
instead it relays the intracellular signals.20

MAPK/ERK pathway has many proteins

kinases which serve as a vehicle to transfer the signals from the plasma membrane to the
intercellular targets, Figure 3 shows a part of the ERK pathway starting from the
epidermal growth factor receptor (EGFR) which is a cell-surface receptor. A series of
protein-protein complexes form involving the growth factor receptor-bound protein
(GRB2), the sarcoma kinase (Src) and the focal adhesion kinase (FAK) (cytoplasm
proteins). This enables the activation o f extracellular-signal-regulated kinase (ERK) and
c-Jun NH 2-terminal kinases (JNK), which control the survival, growth and proliferation
o f cells.

5

Extracellular

Membrane

Cytoplasm

Survival, Growth, Proliferation

____________ _______________________ ____

±

^Tumor growth |

Figure 3: The Mitogen Activated Protein Kinase (MAPK) pathway presenting ERK
pathway starting from growth factor receptor (EGFR) a cell-surface receptor protein.
A series of protein-protein complexes form involving growth factor receptor-bound
protein (GRB2), sarcoma kinase (Src) and Focal Adhesion Kinase (FAK)
(Cytoplasmic proteins). Subsequent to this, is converted to activate extracellularsignal-regulated kinase (ERK) and c-Jun NH2-terminal kinases (JNK) kinases, which
can control the survival, growth, and proliferation signaling. Mutations in the
phosphorylation cascade have been implicated in cancer.

Mutations in the phosphorylation cascade have been implicated in cancer.

20

Tyrosine

kinases have been classified as class II tumour suppressor genes, since more than 50% of
18 21

protein tyrosine kinases are mutated in many kinds of human cancer. ’

6

1.3 Src Kinase
Src kinase (related to Sarcoma virus) played an important role in cancer history. In
1911, Peyton Rous discovered that a microscopic particle, which was later known as a
virus, could induce sarcoma (chicken cancer).22 After sixty-five years, it was established
that this virus genes can cause human cancer. Shortly after that, it was recognized that
this gene was the first tyrosine kinase. Src kinase is a cytoplasmic protein, which
transfers a phosphate group from ATP to the phenolic OH group o f Tyr. Src does affect
the MAPK/ERK pathway as schematically illustrated in Figure 3, which affects many
cellular functions. Many studies have shown that Src kinase was involved in a number of
cancers including colon, breast, and pancreas.10" 23‘ 24 As shown in Figure 4, Src kinase
composed of a catalytic domain (blue color) that is attached to small domains, an SIC
(red color) domain and an SH3 (yellow color) domain that target this kinase to specific
protein substrates.27 The SH3 domain consists mainly of (3-sheets as is shown in Figure 4.
By contrast, the S IC domain consists of mainly a-helices as is shown in Figure 4. ’

Src

kinase recognizes its target proteins through SH2 and SIB domains that are joined
together and to catalytic domain linked by a flexible linker region.28 The phosphorylation
reaction is regulated by three loops, including an activation loop, a nucleotide-binding
loop, and a catalytic loop. Tyr-phosphorylation of the activation loop will lead to a
conformational change or to an intarmolecular interaction between the phosphotyrosine
tail and the S IC domain, as well as between the SH3 and SFC-catalytic domain 29 The
catalytic domain contains the ATP binding site as well as groove to accommodate the
phosphate acceptor region of the protein substrate which controls the kinase activity .10
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catalytic domain
SH3

N-lobe
activation
loop

connector

SH2

C-lobe

Figure 4: Crystal structure of the Src kinase which consists of SH2 domain, SH3
domain and catalytic domain that consist of activation loop, C-lobe, and N-lobe.
Copyright 2007 National Academy of Sciences, U.S.A.27

1.4 Inhibitors
Enzyme inhibitors interact with enzymes and reduce their activity.’0 They are
usually specific in their action and can significantly reduce the enzyme activity, without
causing enzyme denaturation. Binding of an inhibitor can prevent a substrate from fitting
into the enzyme's active site which can block enzyme-catalyzed reactions/ Enzyme
inhibitors can be classified according to their action on their target enzyme into reversible
and irreversible inhibitors. 28 29 Enzyme inhibitors of kinases have emerged as the most
promising target for drug design in recent years.16 Reversible inhibitors can be classified
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•

Com petitive inhibitors that resemble the substrate and thus compete with the
substrate for the active site o f the enzyme (Figure 5).

•

Uncom petitive inhibitors that bind only to the complex formed between the
enzyme and the substrate and not to the free enzyme (Figure 5).

•

Non-competitive inhibitors that can bind to the enzyme regardless of whether a
substrate is bound or not. It usually destroys the catalytic activity of the enzyme,
either by binding to the catalytic site or by causing a conformational change in the
catalytic site. However, they normally do not bind to the substrate binding site
(Figure 5).

Competitive Inhibitor

Substrate
Enzyme

Enzyme

/

Active site
Substrate

Substrate
Enzyme

Noncompetitive
Inhibitor

Inhibitor

Figure 5: Diagram showing the interaction mechanism of the enzyme, the substrate,
and the competitive, non-competitive, and uncompetitive inhibitors.
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Studying enzyme inhibitors is highly valuable in order to provide a better understanding
of the role of kinases in cancer and for the development of anticancer drugs.10 In general,
the distance and the angles between the catalytic residues of the enzyme and the substrate
must be exact in order for the catalysis to occur. Any mutation in the residue which is
close to the active side can cause a remarkable variation in the enzyme activity.30 In the
biological system, A small molecule inhibitor can interact with the tyrosine residue in the
activation loop, which will affect the kinase activity by blocking the phosphorylation site
and changing the conformation in the Src kinase causing its deactivation.30’31 As Figure 6
shows, in the case of inactive kinase, SH2 and SH3 domains bind to the kinase domain,
holding it in an inactive conformation. The SH2 domain binds to an inhibitory phosphate
on a Tyr residue close to the carboxyl terminus (C- loop).

O p e n , activ e S rc

C losed, Inactive Src

Figure 6: Conformational changes in the structure of Src kinase in the presence
of kinase inhibitor. Adapted from ref 26.
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In the case o f kinase activation, the Src kinase will arrange the activation loop in the
active site and at the same time releases the SH3 domain to bind to the target as it shown
in Figure 6.26,30
Molecules such as 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-lH-indol-2yl)methylene]-lH-indole-5-sulfonamide

(SU6656),31

butyl)pyrazolo-

(PP1),32,33

(3,4d)

pyrimidine

4-amino-5-(methylphenyl)-7-(t4-amino-5-(4-chlorophenyl)-7-(t-

butyl)pyrazolo[3,4-d]-pyrimidine (PP2) have been identified as competitive tyrosine
kinase inhibitors (Figure 7).31,34 Control experiments were recorded in this approach by
using competitive inhibitors that have not been classified as Src inhibitors such as Nbenzyl-l-aminobenzotriazole (BBT)35, 37 and 1-phenyl-17/-pyrazolo[3,4-i/]pynmidin-4amine (PP3) (Figure 7).32,39
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PP3

PP2

PP1

SU6656

BBT

Figure 7: Chemical structures o f established Src kinase inhibitors, including
PP1, PP2, and SU6656. On the other hand, PP3and BBT are not Src kinase
inhibitors and are used as controls.

1.4.1 Kinetics o f Enzyme Reactions
Rate of chemical reactions can be expressed in mathematical terms.6, 39 An
equation to describe the rate of product formation in any reaction contains a rate constant
(k) and the substrate concentration that changes during the course of reaction. A simple
12

reaction A—>B, the concentration of the product [P] changes as a function o f time is
d\P]ldt, where [A] is the concentration of the substrate at any time. Eq. 1 shows the
relationship between the rate and the reactant concentration:

d[P]
= k[A]
dt

(Eq. 1)

The rate constant is related to the activation energy and can be changed by the addition of
a catalyst.

Enzyme inhibitors are substances that decrease the rate o f an enzyme-

catalyzed reaction. Measuring the enzyme kinetics is used to characterize the enzymes
with regard to their substrate affinities and maximal reactions rates.39 The rate o f the
catalyzed reactions is usually defined by comparing the change in the reactant or the
product concentration over the time. When the rates o f these processes are measured,
Michaelis-Menten kinetic plot can often be applied to the data (Figure 8). Vmax is the
maximum rate of the reaction at a defined enzyme concentration and has the units of
moles o f product per unit time. Thus Vmax is a constant for a fixed concentration of
enzyme. If the enzyme concentration is increased or decreased, Vmax will increase or
decrease respectively. Vmax is the limiting rate as substrate concentrations increase. Km is
the concentration o f substrate that leads to half-maxima of the rate.39 By measuring the
rate o f substrate V at different substrate concentrations [s], Km and Vmax can be calculated
by the methods o f Michaelis-Menten (Figure 8).39,40 The substrate concentrations change
continuously when close to Km and therefore influence the rate of the reaction, as is clear
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from th e relation ship b etw een [S] and V in Eq. 2:

d[s] _
dt

Figure

8

_ Vmax •[*]

(Eq. 2)

: Michaelis-Menten kinetics. The initial rate V (moles/ time) versus the

substrate concentration [S] (pM), where Vmax is maximum rate; Kra is the substrate
concentration when vis one-half Vmax Adapted from ref 39.

Plotting the same data as a Lineweaver-Burk plot provides a method to determine Vmax
and Km. The Lineweaver-Burk equation is a reciprocal o f the Michaelis-Menten equation
(Eq. 2) as it shown in (Eq. 3).
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1

v

Km

1

Vmax

+

—

Vm

1

x

[5]

(Eq. 3)

A plot o f l / V versus 1/[S] is a straight line (Figure 9). Vmax is determined by the point
where the l/V = 0. The slope of the line is Km / Vmax. Thus Km equals Vmax times the
slope of line. This is easily determined from the intercept on the X axis (figure 9).39,41

l/V

1/ 1

Figure 9: Lineweaver-Burk plot. 1/[S] is the substrate concentration (gM), 1/Vmax
is maximum rate, 1/Kmis the substrate concentration, and the slope is Km/Vmax
Adapted from ref 39.

1.5 Determination of Kinase A ctivity
Over the last years, several methods were employed for the detection of the kinases
activity including fluorescence,42’ 43‘ 44 surface Plasmon resonance (SPR),45’ 46 matrix15

assisted laser desorption ionization (MALDI),46’ 47 and radioactive isotopes labels. 2Plabeled ATP (Figure 10) is used for monitoring catalyzed- phosphorylation reaction, 48
which allows for easy detection and measurement of the phosphorylation reaction .49,50
Although these methods are sensitive, they require a necessary light source which
increases the cost o f the analysis .51

N
<X

O
o
O
O" 3 2 p _ 0 _ p _ 0 _ p _ 0
Q-

Ò'

N
\

Ò'

OH OH

Figure 10: The stmcture of y-32P labeled ATP.

1.6 Detection o f Kinase Activity Using Modified ATP
Since protein phosphorylation involves the transfer of the y-phosphoryl group from
ATP to the peptide, there are several studies about different ATP analogues to detect the
kinase activity and the phosphorylation reaction. Several research groups have modified
ATP to provide various detection methods including Allen e t a l.

They have

synthesized ATP-y-S analogs (Figure 11) as a phosphodonor to various substrates for
analog-specific kinases (AS), permitting delivery of thiophosphate to individual kinase
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substrates .52 This strategy relies on the nucleophilicity o f the thiophosphate group, which
can be modified by reaction with sulfur-selective electrophilic reagents. Our group as
well has used ATP-S to detect the peptide phosphorylation by kinase-catalyze reaction.54.
Figure 11 is showing the chemical structure o f ATP-S.

NH
N

<'
So
o
Il
II
II
o —P - O - P - O - P —0 -1

i
o

o

i

i
O-

N
n

L -"u \
OH

OH

Figure 11 : The structure of ATP-y-S.52

Also,

Shokat et al.

55

have

used

a

radiolabeled

version

of ATP

analog

[^-(b en zy l) ATP-y-S] as is shown in Figure 12. The use of that ATP analog was to label
endogenous substrates and then determine this phosphorylation reaction .55
Gouverneur et al56 also have modified other ATP analogues. The ATP-analogues were
modified with y-phosphate tags incorporating azides, alkynes and alkenes as shown in
Figure 13. The compounds are attached to the ATP via a P -0 or P-N bond. The novel
ATP analogues were then reacted with the substrate in the presence of the protein kinase
to catalyze the phosphorylation reaction, and then the phosphorylation was detected . 56
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NH

Figure 12: The structure of [//’-(benzyl) ATP-y-S],

R1 = NHCH2C = C H

R5 = NHCH2C H = C H 2

R9 = 0(CH2)jBr

R2 * NH(CH2)2C = C H

R6 • NH(CH2)6 N3

R10 = H N - ^ j >-N3

R3 = NH(CH2)3C=CH

R7 = 0(CH2)2N3

R4 = 0(CK2)3C = C H

R8 = NH(CH2)20(CH)20(CH2)0(CH2)2 N3

Figure 13: y-phosphate mcxiified ATP analogues 1-10 that has been used to label the
phosphate group.
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Our group also has synthesized another ATP analog using ferrocene (Fc). Fc and its
derivatives became very popular molecules for bioanalytical applications because of their
stability under physiological conditions.57, 58 Furthermore; the electrochemical behavior
of Fc is fully reversible undergoing a one electron redox process .5 9 ,60

Fc

4 .... ►

(Eq. 4)

Fc+ + e

The y-Fc labeled ATP (Figure 14) was used as a co-substrate for the catalyzedphosphorylation reaction as will be described in the following section .61

Figure 14: The Fc-ATP conjugated structure.61

In this section, I will introduce some electrochemical detection methods including the
detection

of the thiophosphorylation

reaction, which

was achieved by using

adenosine 5'- [y-thio] triphosphate (ATP-S). For this purpose, a biotinylated peptide is
immobilized on a streptavidin-coated screen-printed carbon electrode surface as shown in

19

Figure 15. Protein kinase catalyzes the transfer of a thiophosphate group to the Ser
residue of the peptide. Next, Au nanoparticls, having high affinities for sulfur, were
bound to the thiophosphorylated substrate peptide attached to the surface. The
electrochemical response obtained from oxidative decomposition of the Au nanoparticls
in the present of chloride ions allowed to monitoring the activity o f protein kinase .54

Potential (V)

Figure 15: Detection of kinase-catalyzed thiophosphorylation using adenosine 5'- [y-thio]
triphosphate (ATP-S) immobilized on carbon electrode, which is coated with streptavidin.
Protein kinase catalyzes the transfer of a thiophosphate group to Ser residue of the peptide.
The incubation of the thiophosphorylated peptide with Au nanoparticles causes the
attachment of the Au nanoparticles on the surface which can be detected electrochemically
by using Cl' ions.54
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Green and Pflum63, Kerman e t a t 1 have used ATP-biotin as a co-substrate to convert the
peptide to its biotinyated phosphopeptide by protein kinase-catalyzed phosphorylation
reaction. For example, Kerman used the electrochemistry method to detect the
catalyzed- phosphorylation reaction by using (CK2) kinase (Figure 16).62 The method is
based on labelling a specific phosphorylation event with Au nanoparticles, followed by
electrochemical

detection.

The

phosphorylation

reaction

is coupled

with

the

biotinylation of the peptides using a biotin-modified ATP. The biotinylated kinase
peptide is exposed to streptavidin-coated Au nanoparticles, then the high affinity
between the streptavidin and biotin results in the attachment of Au nanoparticles on the
peptide biotin. Subsequently, the electrochemical response (at 1.2V for 120 s) can be
interrogated from the Au nanoparticls oxidation in acidic environment (0.1 M HC1). As a
result of this oxidation, [AuCU] ~ ions will be produced and the bimolecules will be
oxidized .62

A T P -biotin
Protein

........... — .....
C K 2 K in ases

Figure 16: The phosphorylation reaction by using ATP-biotin conjugated and CK2.

1.7. Electrochemical Detection o f Kinase-Catalyzed
Phosphorylation Reaction using Fc-ATP
The detection of kinase activity using an electrochemical approach exploits a FcATP conjugate reported in the literature.64' 65' 65’ 66 The surface immobilization o f the
21

peptide onto the Au electrode surface was achieved v ia sulfur bond, and then the peptide
was phosphorylated in a kinase-catalyzed reaction with ATP-Fc conjugates (Figure 17).64
Furthermore, cyclic voltammetry (CV) as an electrochemical technique was used to
detect the phosphorylation reaction.

67

Figure 17: The target peptide with the hydroxyl group is immobilized on Au electrode
via

sulfur bond. The kinase catalyzed reaction occurs in the present of the protein kinase

and Fc-ATP conjugate as co-substrate.

Also in our group, the

stability of the peptide immobilization was improved by

immobilizing the peptide on Au electrode v ia Lipoic acid-NHS ester which has dialkyl
disulfides (RS-SR) bond as is shown in Figure 18.65’67 The use of dialkyl disulfides is that
films could result in multilayer formation (rather than a one-layered film as in SAMs) by
precipitation due to their lower solubility compared to thiols. ’

The succinimide group

in lipoic acid NH- ester will serve as a good leaving group, which will help to immobilize
the target peptides on the surface. The protein kinase catalyzes the phosphorylation

22

reaction in the p resen t o f F c -A T P as a co-su bstrate (F igu re 18). T h e electroch em ical

detection then provided to detect the phosphorylation reaction

65 , 68

Figure 18: The target peptide with the hydroxyl group is immobilized on Au electrode
via

lipoic acid NHS ester. The kinase catalyzed reaction occurs in the present of the

protein kinase and Fc-ATP conjugate as co-substrate.

In this approach, the preparation o f Fc-ATP and the lipoic acid active ester as described in
the literature ,68 and the detection of the kinase-catalyzed reaction by the electrochemical
method

Also, the electrochemical method was used for measuring protein kinase

inhibitors potency. The procedure for the preparation of the Fc-ATP conjugates and lipoic
acid NHS-ester is summarized in Scheme 1 61 and Scheme 269
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Fe

78%

'
Fe

1.2 eq. TEA
1.2 eq. HBTU
DCM

H

80%

a-TFA, DCM
b-TEA

O

^

V

i
Fe

“-N

NH2

H

Scheme 1: The synthesis route for the Fc-ATP conjugate. The ferrocenecarboxyhc acid
was added to t-butyl-6 -aminohexylcarbamate in the present of dichloromethane (DCM),
triethylamine (TEA) and

0-( 1H-Ben/otriazol-1-yl)-N,N,N’,N '-tetramethyluronium

Hexafluorophosphate (HBTU). Then, the product was added to the DCM, Trifluoroacetic
acid (TFA), then TEA was added. Then, adenosine 5'-triphosphate (ATP) was added into
of dry dimethylformamide (DMF) and dicycloohexylcarbodiimide (DCC) and (MeOH).
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Scheme 2: The synthesis scheme of lipoic acid NHS ester presenting the addition of
N-hydroxy

succinimide

(NHS)

and

lipoic

acid

in

the

present

of

dicycloohexylcarbodiimide (DCC).

Using Fc-ATP, the following assay was developed to determine the kinase activity. The yFc labeled ATP was used as a co-substrate for the phosphorylation of the peptide that is
immobilized on the Au electrode surface in the presence of protein kinase as is shown in
Scheme 3. The use of the electrochemical techniques was also utilized in this approach to
investigate the effect of specific inhibitors o f the Src kinase such as PP1, PP2, and
SU6656 on the determination o f the Src kinase activity. Also, there was investigation on
some inhibitors that have been classified as a non-inhibitor of the Src kinase such as
PP3and BBT. This was used to monitor the effect o f all of them on Src kinase
electrochemically as shown in Scheme 3.
After the transfer o f the y-Fc phosphate to the peptide substrate, the Fc group attached to
the peptide is electrochemically observed using cyclic voltammetry (CV) and square-wave
voltammetry (SWV) or differential-pulse voltammetry (DPV).

25

Inhibitor + Sre kinase

*
Fc-ATP

Q = Peptide

•= T y r

< * = P _ Ft

Scheme 3: The principle of the electrochemical detection of kinase activity is based on
the phosphorylation of Tyr peptide I the present of Src kinase and Fc-ATP. The
electrochemical detection was provided in the present of small molecule inhibitors. Src
kinas cry stal structures is from Protein Data Bank (1AD5 and 2SRC)

Measurements were performed by three electrode cell system, which consists of working
electrode which is the peptide-modified gold electrode, a Pt wire was the counter
electrode, and the reference electrode was Ag/AgCl 3M KC1 which was placed in a
separate cell and connected to the analyte cell via a salt bridge (KNO 3 agar) to prevent
Cl ions leakage into the measurement system. Then electrochemical techniques such as
CV, SWV, or DPV are used to explore the properties of the system.

68
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1.8. Electrochemistry
In general, an electrode reaction involving a redox species in solution can be
written as O + n e — ► R, where O refers to the oxidized species that is converted into the
reduced form R by the addition of n number of e - electrons.
Cyclic voltammetry (CV) is probably the most popular electrochemical technique utilized by
researchers.70 In the CV technique, the information is presented by plotting the current
against the potential resulting in a cyclic voltammogram (Figure 19).

71

Figure 19: Typical cyclic voltammogram where ipc and ipa show the peak
cathodic and anodic currents respectively, Epc and Epa the anodic peak potential
and the cathodic peak potential and E° is known as the half-wave potential for a
reversible reaction. Adapted from ref 70.
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The information obtained from a CV consists of the anodic peak current (ipa), the
cathodic peak current (ip0), the anodic peak potential (Epa) and the cathodic peak potential
(Epc). E° is the potential for the reversible redox couple and is calculated as follows :7 1 , 72

E° = (Epa + Epc) / 2

(Eq. 5)

E° is also known as half-wave potential and also designated as E 1/2. The measured E° is
part of the Nemst equation:

E = E° + R T / n F (In C0/CR)

(Eq

6

)

where E is the potential applied to the cell, R is the universal gas constant (8.314 J/mol
K), T is the absolute temperature (K), F is Faraday’s constant (96485 C/mol), n is the
number of electrons in the redox process, and Co and C r are the concentrations o f species
O and R respectively. Furthermore, the current is affected during the redox process as
shown in the following equation : 71

ip = (n2 F2/ 4 R T) A

r

u

(E q.7)

Where A is the area o f the electrode, T (footprint) is the surface coverage or footprint of
the molecule bound onto the electrode surface and 1) scan rates. This variable can be
calculated using the following equation:
28

r= Q/nFA

(Eq. 8 )

where Q is the charge o f the integrated cathodic or anodic peak. Also, the surface
electrochemistry reaction for a reversible redox compound, the current ration ipa/ipC is
equal to 1 .
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2. OBJECTIVE
Since we have described earlier in Section 1.1 the importance o f the MAPK
signalling pathway in regulating the phosphorylation reaction, which affects the cells
function, Research in this thesis focuses on one of the kinases o f the MAPK pathway.
The major objective of this research is to develop a methodology to detect and quantify
the activity of Src kinase which is part of the ERK/MAPK pathways (Figure 3). For the
purpose, Fc-ATP was used as co-substrate in the Fc-phosphorylation of a surface bond
Src peptide. The results described here also include a preliminary evaluation of Src
inhibitor using an electrochemical method. Finally, a summary o f the research
accomplishments will be discuss in the context of existing technologies, and provide a
brief outlook of future research will be provided.
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CHAPTER 2

2. E xperim ental Section
2.1. General Experimental Conditions
Src kinase was purchased from Sigma Aldrich, and the substrate peptide
EGIYDVP was purchased from Cell Signaling Technology. The E is glutamic, G is
glycine, I is isoleucine, Y is tyrosine, D is aspartic acid, V is valine, and P is proline.
Adenosine 5’-[y-ferrocene] triphosphate Fc-ATP and lipoic acid-NHS ester were
synthesised according to the procedure published elsewhere . 10 Gold electrodes (99.99 %
purity) with a surface area of 0.02 cm 2 were obtained from CHInstruments. Polyethylene
glycol-SH (5%) (PEG-SH) was purchased from Sigma Aldrich. All experiments were
conducted in aqueous conditions using ultra pure water (18.2 MQ cm) from a Millipore
Milli-Q system. 4-amino-5-(methylphenyl)-7-(t-butyl)pyrazolo- (3,4d) pyrimidine (PP1),
4-amino-5-(4-chlorophenyl)-7-(/-butyl)pyrazolo[3,4-d]-pyrimidine (PP2), 1-phenyl-1//pyrazolo[3,4-i/]pyrimidin-4-amine

(PP3),

and

2,3-dihydro-N,N-dimethyl-2-oxo-3-

[(4,5,6 ,7-tetrahydro-1H-indol -2 -yl)methyl ene] -1 H-indole-5 -sulfonamide
inhibitors

were

provided

by

the

Canadian

Blood

Services.

(SU6656)
A-benzyl-1-

aminobenzotriazole BBT was prepared in D.W. Litchfield’s laboratory (Biochemistry
department at UWO).

31

2.2. Synthesis of (N-hydroxy succinimide activated ester of
lipoic acid) Lipoic acid NHS Ester
The preparation of Lipoic acid NHS ester was as described in the literature .69’ 70 Nhydroxy succinimide (NHS) (1.5 g, 13.5 mmol), and N,N'-dicyclohexyl-carbdiimide
(DCC) (2.7 g, 13.5 mmol) were dissolved in dry dioxane (25 mL). A solution o f lipoic
acid (2.5 g, 13 mmol) in dry dioxane (20 mL) was added slowly and the stirred solution
was left for 48 h at room temperature. The dicyclohexyl urea (DCU) precipitate was
filtered and the solvent was evaporated. The powder was dissolved in 2.5 mL of 2propanol and left overnight at 4 °C. A white precipitate formed was filtered and dried.
Then

the precipitate

was

filtered and

dried.

The product was characterized

spectroscopically by using *H NM R spectroscopy. The spectroscopic properties are
identical to those described in the literature .6 9 ,70
A light yellow powder was lyophilized with

66

% yield of lipoic acid- NHS ester. !H-

NM R (D 20): 5 3.5 (m, 1H, S-CH2-CH2),3.15-3.06 (m.2H, CH 2 -CH 2-S), 2.79(d, 4H, COCH 2 -CHr OC), 2.6 (t, 4H, OC - C H ,-C H A 2.42-2.51 (m, 1 H ,, S - CH 2 - CH? - CH-S),
1.9-1.82 (m, 1H, S - CH 2 - CH 2 - CH-S), 1.79-1.69 (m, 4H, S-CH-CH 2-C H 2-C H 2), 1.5
(m, 2H, CH 2-C H 2-C H ^ C H 2-CO) ppm. MS (El) m/z: calc, for Ci 2H 17 N 0 4S2: 303.40;
found: 303.38.

2.3. Synthesis of Fc-Adenosine 5'-triphosphate (ATP-Fc)
61 72 73

The preparation of Fc-ATP was as it described in the literature. ’ ’

First, the

reaction was between ferrocenecarboxylic acid (23 mg, 1 mmol) and t-butyl-6 -
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aminohexylcarbamate (334 mg, 1 mmol) that was dissolved in 20 mL o f anhydrous
DCM. Then 1.2 equiv. TEA (0.17 mL) and 1.2 equiv. HBTU (455 mg) were added
sequentially. Then, 1 .2 equiv. o f Boc-NH- (CH 2)6- NH 2 was added to the solution. Then,
the solution of Boc-protected ferrocenyl amine (334 mg, 1 mmol) in 10 mL DCM was
added to a TFA 5 equiv. Then, 0.25 mL TEA was added to convert the TFA salt to the
free amine completely. Adenosine 5'-triphosphate disodium salt

(10 0

mg, 0.18 mmol)

was changed after the ion exchange column into its trimetaphosphate form in the
presence 1.8 mL o f dry DMF and (123 mg) o f DCC; then this solution was added to a
solution o f the previous free amine to form (Fc-ATP) compound (295 mg, 5 equiv.) in 10
mL o f MeOH and 0.25 mL o f TEA resulting in the formation of the Fc-ATP conjugate.
The yield was 50% o f Fc-ATP.
using ^

The product was characterized spectroscopically by

and 31P NM R spectroscopy. The spectroscopic properties are identical to those

described in the literature . 18,51 {31 P} -NMR (5, D 20): -0.8(y) d, J = 21.1 Hz; -11.04(a) d, J
= 19.9 Hz; -23.1(P) t, J = 19.9 Hz. {]H}-NMR (5, D 20): 8.52 (s, 1H, H-8 ), 8.19 (s, 1H,
H-2), 6.10 (d,lH , J = 5.5 Hz, H -l'), 4.73 (s, 2H, Cp), 4.74 (s, 1H, H-2'), 4.53 (s, 1H, H3'), 4.46 (s, 2H,Cp), 4.37 (s, 1H, H-4'), 4.23 (m, 2H, H-5'), 4.20 (s, 5H, Cp), 3.16 (t, 2H,
J=6.5Hz, CH 2),2.79 (q, 2H, J = 7.8 Hz, CH2), 1.31-1.45 (m, 4H, CH2), 1.11-1.25 (m, 4H,
CH2) ppm. MS (El) m/z: calc, for C ^ H ^ cN tO isP s: 818.1; found: 818.2.

2.4. Electrode Preparation
Gold electrodes (99.99 % purity with surface area of 0.02 cm2) have been used as
biosensor substrates, and were prepared in the following manner. First, cleaning o f the
Au electrode required manual and electrochemical polishing. The electrodes were first
33

polished with alumina slurries with particle sizes of 0.3 pm and 0.05 pm, followed by
extensive rinsing with water and sonication with water and ethanol to remove any
polishing residue. The Au electrodes were then electrochemically cleaned and polished
by CV. In the CVs, the potential was cycled between -0.4 and +1.4 V vs Ag/AgCl in
0.2 M H 2 SO4 at a scan rate o f 100 mV s ' 1 .75 CV was used to estimate the geometrical
surface area of the Au surface. This method is based on the electrochemically induced
deposition of an oxygen monolayer on the electrode surface

(AU2O3),

and the

measurement of the charge is related to this monolayer. The area (A) under the cathodic
peak (Epc) on the voltammogram is proportional to the real area of the gold surface and is
therefore an indication for the surface roughness.

75

2.5. Film Preparation
The incubation of the Au electrodes in the solution o f lipoic acid-NHS ester in
ethanol (2 mM) was carried out for three days at 4°C. Next, the substrate peptide
modified electrodes were incubated for 2 h at room temperature. Then, followed by
backfilling with 0-[2-(3-Mercaptopropionylamino) ethyl]-0'-methylpolyethylene glycol

(5%) (PEG-SH) solution for 15 mm .66' 68' 76

2.6. Src Kinase-Catalyzed Phosphorylation
The activity of the Src kinase was measured using the following condition:

a) The buffer: 3-(N-morpholino)propanesulfonic acid (MOPS) (5 mM) (pH.7.5),
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ethylene

glycol

tetraacetic

acid

(EGTA)

(1

mM),

M gCh

(4

mM),

ethylenediaminetetraacetic acid (EDTA) (0.4 mM), M nC^ (2.5 mM), [3glycorophosphate (2.5 mM),

b) Fc-ATP (200 pM) and Src kinase (1 gg/mL) which were dissolved in the MOPS
buffer that is described in (a).

c)

4-amino-5-(methylphenyl)-7-(t-butyl)pyrazolo- (3,4d) pyrimidine (PP1) (10 pM),
4- amino-5-(4-chlorophenyl)-7-(i-butyl)pyrazolo[3,4-d]-pyrimidine (PP2) (10 pM),
1-phenyl-1 T/-pyrazolo[3,4-i/]pyrimidin-4-amine (PP3) (10 pM),

2,3-dihydro-

N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-lFI-indol-2-yl)methylene]-lH-indole5- sulfonamide (SU6656) (10 pM), and A-benzyl-l -aminobenzotriazole (BBT)
(10 pM), all the inhibitors were dissolved in dimethyl sulfoxide (DMSO) at room
temperature.

d) Src kinase concentration dependence reactions were determined in 0.7, 0.5, 0.07
and 0.05 pg/mL in MOPS buffer that is described at (a).

e) A series of incubation o f Src substrate peptide modified electrode were taken in the
presence of varying Fc-ATP concentrations (80,100, 120,160, 200 pM).

The phosphorylation reactions were incubated for 2h at 37 °C. After the incubation, the
electrodes were washed multiple times using 2 M NaC 1 0 4 . Then, the washed electrodes
were immersed in to a 2 M NaC 1 0 4 solution for the electrochemical measurement. For
the inhibitors studies, the Src kinase and the inhibitors PP1, PP2, PP3, TBB, and SU6656
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were added to the kinase buffer, while maintaining the working concentration o f the Src
kinase and the inhibitors at lgg/m L and 10 gM, respectively. After 30 min, the kinase
reaction was initiated by the addition of Fc-ATP.

2.7. Electrochemistry
The Fc group attached to the peptide can be observed electrochemically using either
cyclic voltammetry (CV), square-wave voltammetry (SWV), or differential-pulse
voltammetry (DPV). Measurements were performed on an electrochemical workstation
(CHInstruments Potentiates 660B) in a 2 M NaC 1 0 4 aqueous solutions as a supporting
electrolyte at room temperature. When the potential is scanned electron transfer to and
from the electrode occurs at Fc as the redox-active site. The protein will direct electrical
communication between the redox site and the electrode which can be determined by CV,
SWV, or DPV. DPV and SWV, as new electrochemical techniques, were employed in this
study for the analytical measurement because CV measurements may not provide enough
sensitivity.71
Characterizing the Au surface electrochemically was achieved using CV. CVs were
performed in a 0.1 M sodium phosphate buffer (pH 7.4) containing (5 mM) [Fe(CN)6]3’ 4'
as a redox probe to give a good measure o f the blocking properties of the gold electrodes
surface during the immobilization steps.68 We tried to examine the electrochemical
behaviour after each step o f our biosensor experiment. Subsequently, the surface
coverage T (footprint) can be determined using (Eq. 8).
The characteristics o f electrode reaction kinetics can be investigated by applying various
scan rates. If the scan rate is increased and the Faradaic current increases this indicates
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that fast electron transfer kinetic is occurring on this electrode. CVs were recorded at
various scan rates (v), and when the scan rate is changed the current response also
changes. A series of linear sweep voltammograms were recorded at different scan rates
(10, 20, 40, 80, 100 mVs'1).77

2.8. Calculation of Kinetic and Inhibition Constants
The initial time dependence o f Src kinase reactions were determined at various
peptide concentrations. The reaction was stopped after 5,10, 30, 60, 90, and 120 min, and
measurement o f the attached Fc was carried out. The reciprocals o f the reaction rate
values were plotted against the reciprocal o f the peptide concentration, which gives a
linear Lineweaver-Burk curve. Then, we determined the Kmand Vmax values where the y
intercept is 1/Vmax and the ^ in te rc e p t equal to -1/Km. Also, the data were plotted in the
form of a Michaelis-Menten curve for further determination of Km and Vmax-70

2.9. X-Ray Photoelectron Spectroscopy (XPS)
The XPS analyses were carried out with a Kratos Axis Ultra spectrometer using a
monochromatic A1 K a source (15 mA, 14 kV). The instrument work function was
calibrated to give a binding energy (BE) o f 83.97 eV for the Au 4f7/2line for metallic gold
and the spectrometer dispersion was adjusted to give a BE of 932.62 eV for the Cu 2p3/2
line of metallic copper. The Kratos charge neutralizer system was used on all specimens.
The analyses were carried out over an analysis area of 300 x 700 microns using a pass
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energy of 160 eV. High-resolution analyses of an area 300 x 700 microns were recorded
with a pass energy of 20 eV. Spectra were charge-corrected by reference to the main line
o f the carbon Is spectrum set to 284.7 eV. Spectra were analysed using CasaXPS
software. The XPS experiment was carried out at Surface Science Western at the
University of Western Ontario by Mark Biesinger.
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CHAPTER 3

3. Results an d Discussion
An electrochemical approach was implemented by detecting the kinase-catalyzed
reaction on gold electrodes. Using Fc-ATP as the co-substrate allows the use o f the
electrochemical approach for the detection of kinase-catalyzed phosphorylation by using
Fc-ATP as the co-substrate. The substrate tyrosine peptide is immobilized on the gold
surface via an Au-S bond. Src kinase catalyzes the reaction by transferring a y-phosphateFc group to the tyrosine residue on the peptide. The Fc group attached to the peptide is
electrochemically observed using CV and SWV.
Characterizing the surface was done using 0.1 M sodium phosphate buffer (pH 7.4)
continuing 5 mM [Fe(CN)e]3/4‘ to give a good measure o f the blocking properties of the
gold electrode surface during the immobilization steps, which is shown in Scheme 4.

18

We tried to examine the electrochemical behaviour after each step o f our biosensor
experiment. First, a CV was recorded on the bare gold electrode surface before any
immobilization as is shown in Figure 20.

The CV shows a reversible redox peak,

observed at 280 mV at scan rate o f 100 mV s'1. Then, the CV was recorded after
incubation with lipoic acid NHS ester for three days (Figure 20), and also after the
peptide incubation for 24 h (Figure 20). Back-filling the surface using PEG-SH was
provided to avoid unwanted chemisorptions. The resulting CV, Figure 20, shows almost
completed blocking of the modified electrode surface. As is shown in Figure 20, the large
peak-to-peak separation (AEP) o f the peaks compared to those recorders on the bare Au,
accompanied by decreases in the peak currents.68,69
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Scheme

4:
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immobilization of lipoic acid NHester

on
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electrode

surface. (B) The immobilization
of the peptide (EGIYDVP) on the
gold

electrode

surface.

(C)

Control the surface coverage to
coat the empty electrodes surface
by using PEG-SH. (D) Protein
kinase catalyzes the reaction of
the peptide phosphorylation.
D
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The decreases in peak currents are because the redox probe is unable to approach the Au
surface. The peak separation shows that the electrochemical reaction is getting less and
less reversible.68 69
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Figure 20: Surface characterization of peptide biosensor surface in 0.1 M sodium
phosphate buffer (pH 7.4) continuing (5 mM) [Fe (CN) 6]3 + as a redox probe. CV of
bare gold electrode with Ferric /Ferrocyanide KNO^ (blue line). CV of electrode after
the incubation of Lipoic acid NHS ester for three days (red line). CV after the peptide
incubation for 2h (green line). CV of the electrode after PEG-SH incubation for 10
min (violet line).

To further explore the surface of the biosensing interface, the surface sensitive X-Ray
photoelectron spectroscopy technique (XPS) was applied after the kinase-catalyzed Fcphosphorylation reaction.68 The XPS results are identical to those described in the
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literature.68 The XPS survey scan reveals the presence o f S, C, O and N atoms in the
sample, as shown in Figure 21. The binding energy (BE) was 83.45 eV for the Au 4 f 7/2
line for metallic gold. The presence of S was due to the presence of the NHS-ester, and
yielded a spectrum for S 2p that gives rise to two doublets. The first doublet was for the S
2p2/3 peak with a BE of 161.68 eV (Figure 22). The second doublet was S 2pi/2 peak with
BE of 162.86 eV (Figure 22). The first signal S2p3/2 represent S in the thiol group species
while the other signal 2py2 represents a physisorbed.68 Additionally, the high resolution
XPS result after the Src kinase Fc-phosphorylation gives a peak of Fe 2p3/2at BE 707.15
eV, which matches the literature values.

68

Figure 21: The XPS survey scans of Au surface, after the Src kinase
phosphorylation-catalyzed reaction, reveal the presence of Fe, O, N, C and S
atoms.
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Figure 22: High resolution XPS showing the presence of S 2p3/2 peak with a BE of
161.68 eV, and a second peak of S 2pi/2 peak with BE of 162.86 eV. Also, the high
resolution XPS gives a peak of Fe 2p3/2at BE 708.07 eV.
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The kinase-catalyzed Fc-phosphorylation reactions of the peptide-modified sensor
surface, shown in Scheme 4, were investigated electrochemically. A current density
response for the Fc-phosphorylation is characterized by a reversible couple at - 450 mV
(vs. Ag/AgCl reference electrode) which is due to electron transfer to the y-Fc-phosphate
group attached to the tyrosine residue of the surface-bound peptide as the CV shows in
Figure 23. The value of E° was determined from the CV to be at -4 2 0 (±15) mV and it is
similar to the value that reported at another studies in which a value of E° of - 329
(±11) mV was obtained.68 The current ratio determined i s -0 .9 6 ± 0.2, which is close to
unity, suggesting a reversible redox reaction. Also, DPV response of a peptide-modified
electrode yielded a peak at -

400 mV (Figure 24). Significantly, when the

phosphorylation reaction was performed in the absence of Src protein kinase, no Faradaic
response was observed in either CV or DPV (Figure 23 and 24). This demonstrates that
the redox signal is due to the Fc group which is attached to the peptide surface.64’ 65
Figure 23 shows the CV peak separation AE in the 40-50 mV range which suggests that
there is only one electron involving in this redox process.66 The surface coverage T was
determined by integrating the reduction peaks, and it was found to be in 2 - 7 x l0 'u mol
cm’2 range.68
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15

Figure 23: CV (from 0 to 800 mV and back) of the peptide modified Au electrode for
detection of Src kinase (lpg m l/1) in the presence of the Src kinase (red line) and in the
absence of Src kinase (blue line), in 2 M NaC104 vs. Ag/AgCl utilizing a Pt wire as the
counter electrode at a scan rate 100 mV/s.

Potential (mV)

Figure 24: DPV (from 100 to 700 mV) of the peptide modified Au electrode for
detection of Src kinase (Ipg mL'1) in the presence of the Src kinase (red line) and in the
absence of Src kinase (blue line) in 2 M NaC104 vs. Ag/AgCl utilizing a Pt wire as the
counter electrode at a scan rate 100 mV/s.
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To optimize the experimental conditions, a series of measurements were taken in the
presence o f Fc-ATP concentrations (80, 100, 120, 160, 200 pM) using the same assay
conditions in the presence of 1pg/pl Src Kinase. The SWV measurements show a peak at
~ 400 mV, as shown in Figure 25. As the concentration of the Fc-ATP increased the
current response increased, which showed the specificity of the phosphorylation reaction
as it shows in Figure 25 and Table 1. Moreover, a control experiment in the absence of
FC-ATP showed no response in the absence of ATP-Fc in the presence of 1pg/pl Src
kinase reaction (Figure 25).65 The dependence of the current density on Fc-ATP
concentration is plotted with an equation of y - 0.03x and R 2 of 0.9904 as is shown in
Figure 26. The response of the dependence of Fc-ATP concentration on the current
signals is similar to the response that reported in the literature.65

20 0
160
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80
0

pM
pM
pM
pM
pM

Potential (mV)
Figure 25: SWV (from 200 to 600 mV) of lpg/mL Src kinase and various Fc-ATP
concentrations 200, 160, 120, 100, 80 pM, and a control experiment in the absence of FcATP and in the presence of 0.1 pM Src kinase in 2 M NaC104 vs. Ag/AgCl utilizing a Pt
wire as the counter electrode at a scan rate 100 mV/s.
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Figure 26: Plot for the SWVs of current density and Src kinase concentrations. The
condition was as described in Fig 25. Error bars indicate the standard deviation based
on three measurements.

Charge
SP.Area
Fc-ATP
# molecules
concentration
(Q)
(Molecules)
(MM)
(C )
200 pM
5.36* 10'7 3.35xl012

Foot print
(A2/molecules)

(Mole/cm2)

376

4.42x10-“

(D

160 jiM

4.88xl0-7

3.05xl012

413

4.02x10-“

120 fiM

4.15xl0-7

2.56xl012

491

3.38x10-“

100 pM

1.26xl0-7

7.12xl012

1766

9.40xl0-12

80 pM

1.14xl0-7

6.05xl012

2078

7.99xl0-12

Table 1: Comparison of the Fc-ATP and quantify the surface coverage by using (Q =
n F A T) Q is the charge, A is the area of the electrode, F is the faraday constant, n is
the number of the e ', and T is the surface coverage.
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Another optimization experiment was conducted in the presence of various Src kinase
concentrations (0.7, 0.5, 0.07, and 0.05 pg/pl), under the same assay conditions in the
presence o f 200 pM o f Fc-ATP as shown in Figure 27. As the concentration o f the Src
kinase increased the current responses increased as shown in Table 2.64 Moreover, a
control experiment in the absence of Src kinase showed no response in the absence o f Src
kinase in the presence o f Fc-ATP demonstrated the successful suppression of the non
specific adsorption o f interfering biomolcules on the surface using the PEG-SH
modification (Figure 27).64 The dependence of the current density on Src kinase
concentration is plotted with an equation of y = 0.6259x and R o f 0.9903 as is shown in
(Figure 28).

0.7 jig ml/1
im—m 0.5 jig mL'1
0.07 jig Dll/1
■
— 0.05 jig mL'1
0 \xg mL4

Potential (mV)

Figure 27: SWV (from 200 to 700 mV) of 200 ¿iM of Fc-ATP, and various Src kinase
concentrations 0.7, 0.5, 0.07, and 0.05 |ig/mL and a control experiment in the absence
of Src kinase and in the presence of Fc-ATP, in 2 M NaC104 vs. Ag/AgCl utilizing a Pt
wire as the counter electrode at a scan rate 100 mV/s.
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Figure 28: Plot for the SWVs of current density and Src kinase concentrations. The
condition was as described in Fig 27. Error bars indicate the standard deviation of three
measurements.

Foot print
(A2/molecules)

(Mole cm2)

(C )

SP.Area
# molecules
(Molecules)

0.7 j.ig ml

2.15xl0-7

1.69 <109

7457

2.23 <10 12

0.5 jiginl

1.97*1O'8

1.5*108

81512

2.04* 1012

0.007 (iigml

1.27* 10'8

9.99* 107

12583

1.32* 10-13

0.005 jig ml

9.55* 10-9

7.49-107

167779

9.90* 10'14

Src Kinase
concentration
(Hgfail)

Charge

(Q)

(O

Table 2: Comparison of the Src kinase and quantify the surface coverage by using (Q =
n F A T) Q is the charge, A is the area of the electrode, F is the faraday constant, n is the
number of the e‘, and T is the surface coverage.
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The characteristic kinetics o f the electrode reaction can be investigated by applying
various scan rates; when the scan rate is increased, the Faradaic current also increases,
this indicates fast electron transfer kinetics on the electrode.77 CVs were recorded at
various scan rates (v), and when the scan rate was changed the current response also
changed, as shown in Figure 29, for a series o f linear sweep voltammograms recorded at
different scan rates (100, 80, 60, 40, 2 0 ,1 0 m V s1) 77 The total current increases with the
increase in scan rate as shown in Table 3. This is due to the differences in the diffusion
layer, and that tells us about the characteristic of electrode reactions, which have fast
electron transfer kinetics. Plotting the peak current density against the scan rate shows a
linear relationship (Figure 29). A linear relationship is expected for a surface-bound
species indicating the successful immobilization o f the compound onto gold surfaces. See
Equation 7 in section 1.8.

The time dependence o f the phosphorylation reaction was investigated to determine die
phosphorylation kinetics. The reaction was stopped after 5 ,1 0 ,3 0 ,6 0 ,9 0 , and 120 min;65
the surface concentrations were varied by using various peptide densities condition
(Figures 30 and 31). The peak current reached a saturation level, when the incubation of
the assay solution was for 2h. When the reaction was stopped at 150 min, no significant
increase in the reduction peak responses was observed. As shown in Figure 30, when the
kinase reaction was allowed to continue less than 2h, the current response decreased
indicating that the surface immobilization substrate peptides were not phosphorylated
efficiently in the presence o f 200 pM o f Fc-ATP.65
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Figure 29: CVs (from 0 to 0.8V and back) of the Fc-y phosphorvl peptide modified
electrode at varied scan rates of 10, 20, 40, 80, and 100 mV/s. plot of peak current
density vs. scan rate. CV scans recorded in 2.0 M NaC104 vs. Ag/AgCl utilizing a Pt
wire as the counter electrode.

Scan Rate

10mV/s

20 mV/s

40 mV/s

80 mV/s

lOOmV/s

Ipc

0.44 *10‘7A 0.85 xl0-7A

1.5 *10‘7A 2.5 xl0-7A

2.9 xlO’7A

V

0.40 <10-7A 0.80 10*'A

1.8 xl0-7A 2.9 xlO*7A

3.1 x 10*7A

Table 3: The electrochemical properties of CVs data in 2 M NaC104 at various
scan rates (10, 20, 40, 80, 100 mV/s). The ipa anodic peaks current and the ipc
cathodic peaks current showing that the total current increases with the increase in
scan rate.
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Figure 30: CVs for the catalyzed phosphorylation reactions in the presence of 200 pM
Fc-ATP and 1 pM of Src kinase at varying incubation periods at 37°C, 120, 90, 60,
30,10 min in 2 M NaC104 vs. Ag/AgCl utilizing a Pt wire as the counter electrode at a
scan rate 100 mV/s.

1.4

Figure 31: The Plot of CVs of dependence of current density response on the various
incubation times. Error bars indicate the standard deviation of three CVs
measurements.
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The Michaelis-Menten and Lineweaver-Burk plots were described in Section 1.4.1.
Figures 8 and 9. The current values were plotted against the peptide density, giving
linear Lineweaver-Burk plot and Michaelis-Menten plot. The determination of the kinetic
values Km and Vmax was by using the same method, the Km value is 0.250 mM and the
Vmax is 1.61 pmol m in'1 m g'1 as in Figures 32 and 33.

Figure 32: The plots of Michaelis- Menten that shows the values of Vmaxand Km. Error bars
indicate the standard deviation using three CVs measurements for each point.
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Figure 33: The plots of Lineweaver-Burk that shows the values of 1/Vmax and 1/Km.

A selection o f small molecules inhibitors has been provided in this study (Figure7). The
activity of the kinases in the presence and absence of the inhibitors were evaluated which
provided us with information regarding the specificity of the inhibitor.65 CVs
measurements were provided for the kinase catalyze reaction before and after the addition
of various ATP-competitive inhibitors including PP1 (Figure 34), PP2 (Figure 35),
SU6656 (Figure 36) there was no response after the addition of the inhibitors comparing
to the response before the inhibitors indicating insufficient phosphorylation between the
substrate peptide EGIYDVP and the Src kinase. Also, SWVs provide the same behaviour
of response in the present of the inhibitors (Figures 34, 35, and 36). Additionally, the
kinase activity assessed in the presence of various inhibitors concentrations and the
obtained data will provide us the concentration range of the inhibitors, which will be
important in the research o f medical and pharmaceutical fields .65
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Figure 34: (A) CV (from 0 to 800 mV and back) of Src kinase catalyzes reaction
before and after the addition of the inhibitor PP1 ( blue line before the addetion
and red line after the addition). (B) SWV (from 0 to 0.7 V) for the kinase catalyze
reaction before and after the addition of the inhibitor PP1 (blue line before the
addetion and red line after the addition), in 2 M NaC104 vs. Ag/AgCl utilizing a
Pt wire as the counter electrode at a scan rate 100 mV/s. (C) Plot of various
concentrations of the inhibitor PP1. Error bars indicate the standard deviation of
three CVs measurements.
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Figure 35: (A) CV (from 0 to 900 mV and back) of Src kinase catalyzes reaction
before and after the addition of the inhibitor PP2 (blue line before the addition
and red line after the addition). (B) SWV (from 0 to 700 mV) for the kinase
catalyze reaction before and after the addition of the inhibitor PP2 (blue line
before the addition and red line after the addition), in 2 M NaC104 vs. Ag/AgCl
utilizing a Pt wire as the counter electrode at a scan rate 100 mV/s. (C) Plot of
various concentrations of the inhibitor PP2. Eerror bars in the plot indicate the
standard deviation of three CVs measurements.
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Figure 36: (A) CV (from 0 to

900 mV and back) o f Src kinase catalyzes reaction before

and after the addition o f the inhibitor SU6656

line after the addition). (B)

(blue line before the addition and red

SWV (from 0 to 600 mV) for the kinase catalyze reaction

and after the addition o f the inhibitor SU6656

(blue line before the addition and red

line after the addition), in 2 M NaC104 vs. Ag/AgCl utilizing a Pt wire as the
counter electrode at a scan rate 100 mV/s. (C) Plot of various concentrations of
the inhibitor SU6656. Error bars in the plot indicate the standard deviation of
three CVs measurements.

The plots o f the various concentrations of PP1, PP2, and SU6656 inhibitors are presented
in Figures 34-35 and 36. The inhibition of SU6656 on Src kinase activity is faster than
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the PP1 and PP2, when we applied the same concentration InM for all o f the inhibitors as
is shown in Table 4. Optimization experiment was conducted in the presence o f various
inhibitors concentrations (1, 5 ,1 0 ,1 5 , and 20 nM) under the same assay conditions in the
presence o f 200 pM o f Fc-ATP and 1 pg/mL o f Src kinase. All the inhibitors reach a
constant minimum current value at 15 nM which is in agreement with reported values in
the literature67

Current D ensity (|iA cm'2)
Inhibitor
Concentrations

PP1

PP2

SU 6656

In M

18

24

17.3

5 nM

10.7

15

10

10 nM

3

3.4

2.4

Table 4: The current density determination was in the present of various concentrations
(1,5, and 10 nM) of various inhibitors (PP1, PP2, and SU6656).

The activity o f Src kinase was investigated in the presence o f some inhibitors that do not
inhibit the Src kinase such as PP3and BBT. SWVs observe increasing in the current
responses which provided us with information regarding the specificity o f the inhibitor
(Figures 37-38).
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Figure 37: SWVs (from 200 to 800 mV) for the kinase catalyze reaction of Src kinase
in the presence o f BBT which does not inhibit the Src kinase in 2 M NaC104 vs.
Ag/AgCl utilizing a Pt wire as the counter electrode at a scan rate 100 mV/s.

Potential (mV)
Figure 38: SWVs (from 200 to 800 mV) for the kinase catalyze reaction of Src kinase in
the presence of PP3 which does not inhibit the Src kinase in 2 M NaC104 vs. Ag/AgCl
utilizing a Pt wire as the counter electrode at a scan rate 100 mV/s.
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CHAPTER 4

4. Sum m ary an d P erspectives
In this last chapter, key achievements will be summarized and an outlook on future
research will be presented. Protein kinases play a significant role in cellular
communication where they catalyze phosphorylation reactions, which regulate various
functions. Any mutations in these kinases cause many chronic diseases including cancer.
Therefore, detecting the progression o f kinases and controlling them is an important
aspect in the development o f drugs. The idea in this approach is to detect die activity o f
Src kinase catalysis phosphorylation reaction and some o f the inhibitor activity by
electrochemical methods, through labeling the y-phosphate o f ATP with a redox active
ferrocene. Ferrocene as an electroactive reporter will transfer with the y-phosphate o f
ATP to a tyrosine protein side chain o f the Src substrate peptide. Our method has allowed
us to quantify the electrochemical response and provide a simple way to test kinase
inhibition, which may prove the way for high technology for screening o f protein kinase
inhibitors.
This thesis addresses the use o f Fc-ATP and its electrochemical properties. In particular,
the application o f the Fc-conjugate to the study o f the detection o f kinase-catalyzed
phosphorylation reactions was investigated in more detail. Our work was focused on the
extent in the use o f Fc-ATP congregate as a co-substrate for Src kinase-catalyzed
phosphorylation reaction and exploring its electrochemical properties.

Exploring die

usefulness o f the o f the bioconjugate Fc-ATP probe for the electrochemical detection o f
another protein kinases activity will be useful. That is particularly important for
60

understanding cancer and its various stages since the activity o f some o f the kinases will
be enhanced and controlled. Exploring a multiplexed approach for screening of
biochemical signalling pathways and protein kinase inhibitors is important to develop
diagnosis and therapy o f cancer diseases.
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